Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 1.00% Nasdaq Up 1.29%
Streaming
Ticker Tape: On

More On ALIOF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Actelion Ltd. (ALIOF)

-Other OTC
97.21 Up 4.72(5.10%) 3:54PM EDT
Get the big picture on all your investments.
Prev Close:92.49
Open:97.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:97.00 - 97.21
52wk Range:57.10 - 106.12
Volume:2,067
Avg Vol (3m):697
Market Cap:10.80B
P/E (ttm):23.15
EPS (ttm):4.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):19.72
P/S (ttm):5.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :4.03
Quarterly EPS Est (Dec-13) :0.74
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):2.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertensi... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback